Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
45 results
D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
D2.47 - Application of magnetic particle chemiluminescence technology to detect sensitization in patients in Guangzhou, China: a study base on real-world medical data
D2.48 - Evolving Trends in Pediatric Allergy Referrals Over the Past Decade
D2.49 - Impact of Age and Allergen Type on Sensitization Changes in Chronic Rhinitis Children
D2.50 - Hereditary angioedema; single center experience
D2.51 - ‘Allergy Testing’- but why do we need it? A conceptual misunderstanding leading to diagnostic delay and wastage of health care resources in children referred for 'allergy testing' with poorly controlled eczema
D2.52 - Prevalence of sensitization to aeroallergens among atopic children in Ukraine
D2.53 - Prevalence of angioedema in the emergency department at Sant Joan De Déu (Manresa)
D2.55 - Food-Dependent Exercise-Induced Anaphylaxis: Prevalence of Wheat as an Allergen Compared to Other Foods
D2.56 - Diagnostic value of the lymphocyte transformation test for the investigation of drug-induced enterocolitis syndrome (DIES)
D2.57 - Recurrent pleural effusion in patient with hereditary angioedema: a case report
Pagination
Current page
1
Page
2
Page
3
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download